Zainab Alhalwachi

Ms. Zainab Alhalwachi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMariane Daou
Mariane Daou
HKHussein Kannout
Hussein Kannout
MKMariam Khalili
Mariam Khalili
MAMohamed Almarei
Mohamed Almarei
MAMohamed Alhashami
Mohamed Alhashami
OPon behalf of the UAE COVID-19 Collaborative Partnership
on behalf of the UAE COVID-19 Collaborative Partnership
Coronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was found to commonly cause cough and pneumonia. However, non-respiratory symptoms including gastrointestinal disorders are also present and a big proportion of patients test positive for the virus in stools for a prolonged period. In this cross-sectional study, we investigated viral load trends in stools and nasopharyngeal swabs and their correlation with multiple demographic and clinical factors. The study included 211 laboratory-confirmed cases suffering from a mild form of the disease and completing their isolation period at a non-hospital center in the United Arab Emirates. Demographic and clinical information was collected by standardized questionnaire and from the medical records of the patient. Of the 211 participants, 25% tested negative in both sample types at the time of this study and 53% of the remaining patients had detectable viral RNA in their stools. A positive fecal viral test was associated with male gender, diarrhea as a symptom, and hospitalization during infection. A positive correlation was also observed between a delayed onset of symptoms and a positive stool test. Viral load in stools positively correlated with, being overweight, exercising, taking antibiotics in the last 3 months and blood type O. The viral load in nasopharyngeal swabs, on the other hand, was higher for blood type A, and rhesus positive (Rh factor). Regression analysis showed no correlation between the viral loads measured in stool and nasopharyngeal samples in any given patient. The results of this work highlight the factors associated with a higher viral count in each sample. It also shows the importance of stool sample analysis for the follow-up and diagnosis of recovering COVID-19 patients.

20 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Fatme AlAnoutiFatme AlAnouti
Fatme AlAnouti
MMMira Mousa
Mira Mousa
Spyridon KarrasSpyridon Karras
Spyridon Karras
William B. GrantWilliam B. Grant
William B. Grant
ZAZainab Alhalwachi
Zainab Alhalwachi
HAHabiba Alsafar
Habiba Alsafar
Vitamin D has many effects on cells in the immune system. Many studies have linked low vitamin D status with severity of COVID-19. Genetic variants involved in vitamin D metabolism have been implicated as potential risk factors for severe COVID-19 outcomes. This study investigated how genetic variations in humans affected the clinical presentation of COVID-19. In total, 646 patients with SARS-CoV-2 infection were divided into two groups: noncritical COVID-19 (n = 453; 70.12%) and a critical group (n = 193; 29.87%). Genotype data on the GC, NADSYN1, VDR, and CYP2R1 genes along with data on serum 25-hydroxyvitamin D levels were compiled in patients admitted to a major hospital in the United Arab Emirates between April 2020 and January 2021. We identified 12 single-nucleotide polymorphisms associated with the critical COVID-19 condition: rs59241277, rs113574864, rs182901986, rs60349934, and rs113876500; rs4944076, rs4944997, rs4944998, rs4944979, and rs10898210; and rs11574018 and rs11574024. We report significant associations between genetic determinants of vitamin D metabolism and COVID-19 severity in the UAE population. Further research needed to clarify the mechanism of action against viral infection in vitamin D deficiency. These variants could be used with vaccination to manage the spread of SARS-CoV-2 and could be particularly valuable in populations in which vitamin D deficiency is common.

13 February 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
MAMohammed Albreiki
Mohammed Albreiki
MMMira Mousa
Mira Mousa
SASyafiq Kamarul Azman
Syafiq Kamarul Azman
HVHema Vurivi
Hema Vurivi
ZAZainab Alhalwachi
Zainab Alhalwachi
HAHabiba Alsafar
Habiba Alsafar
Introduction: A rapid increase in COVID-19 cases due to the spread of the Delta and Omicron variants in vaccinated populations has raised concerns about the hospitalization risk associated with, and the effectiveness of, COVID-19 vaccines.Method: This case–control study aims to determine the hospitalization risk associated with the inactivated BBIBP-CorV (Sinopharm) and mRNA BNT162b2 (Pfizer–BionTech) vaccines, and their effectiveness reducing the rate of hospital admission between 28 May 2021 and 13 January 2022, during the Delta and Omicron outbreaks. The estimation of vaccine effectiveness of 4,618 samples was based on the number of patients hospitalized at different vaccination statuses, adjusted for confounding variables.Results: Hospitalization risk increases in patients affected with the Omicron variant if patients are aged ≤ 18 years (OR 6.41, 95% CI 2.90 to 14.17; p < 0.001), and in patients affected with the Delta variant if they are aged > 45 years (OR 3.41, 95% CI 2.21 to 5.50; p < 0.001). Vaccine effectiveness reducing the rate of hospital admission for fully vaccinated participants infected with the Delta and Omicron variants was similar for both the BBIBP-CorV (94%, 95% CI 90% to 97%; 90%, 95% CI 74% to 96%) and BNT162b2 vaccines (95%, 95% CI 61% to 99.3%; 94%, 95% CI 53% to 99%), respectively.Discussion: The BBIBP-CorV and BNT162b2 vaccines utilized in the UAE vaccination program were highly effective in reducing the rate of COVID-19-related hospitalization during the Delta and Omicron outbreaks, and further effort must be taken to achieve high vaccine coverage rates in children and adolescents in the global context to reduce the hospitalization risk associated with COVID-19 on an international scale.

16 August 2022 in Pharmacogenomics
Verified
Journal Article
Open access
HMHend Chaker Masmoudi
Hend Chaker Masmoudi
NANariman Afify
Nariman Afify
HAHalima Alnaqbi
Halima Alnaqbi
ZAZainab Alhalwachi
Zainab Alhalwachi
GTGuan K. Tay
Guan K. Tay
HAHabiba Alsafar
Habiba Alsafar
Specific HLA associations with drug hypersensitivity may vary between geographic regions and ethnic groups. There are little to no data related to HLA-drug hypersensitivity on populations who resid... Tweetable abstract What is known about HLA alleles and drug hypersensitivity associations in the populations of North Africa and the Middle East and the potentiality of genomic tools and projects t...

Verified
Journal Article
Open access
PDF file
MKMustafa Tariq Khan
Mustafa Tariq Khan
RAReem Al-dhaleai
Reem Al-dhaleai
SASarah M. Alayadhi
Sarah M. Alayadhi
ZAZainab Alhalwachi
Zainab Alhalwachi
ABAlexandra E. Butler
Alexandra E. Butler
Gene therapy and RNA (ribonucleic acid)-based therapeutic strategies have emerged as promising alternatives to conventional diabetes treatments, significantly expanding the therapeutic landscape using viral and non-viral vectors, and RNA modalities such as mRNA (messenger ribonucleic acid), siRNA (small interfering ribonucleic acid) and miRNA (micro ribonucleic acid). Recent advancements in these fields have led to notable preclinical successes and ongoing clinical trials, yet they are accompanied by debates over safety, efficacy and ethical considerations that underscore the complexity of clinical translation. This review offers a comprehensive analysis of the underlying mechanisms by which these treatments target diabetes, critically evaluating the fundamental concepts and mechanistic insights that form their basis, while highlighting current research gaps, such as the challenges in long-term stability and efficient delivery of RNA-based therapies, and potential adverse effects associated with gene therapy techniques. By synthesizing diverse perspectives and controversies, the review outlines future directions and interdisciplinary approaches aimed at overcoming existing hurdles, ultimately setting the stage for innovative, personalized diabetes management and addressing the broader clinical and regulatory implications of these emerging therapeutic strategies.

Verified
Journal Article
Open access
PDF file
ZAZainab Alhalwachi
Zainab Alhalwachi
Thozhukat  Sathyapalan Thozhukat Sathyapalan
Thozhukat Sathyapalan
ABAlexandra E. Butler
Alexandra E. Butler
SAStephen L Atkin
Stephen L Atkin
Unexplained infertility affects up to 30% of couples and has been associated with heat shock proteins (HSP) and endometrial stress. HSPs and their co-chaperones are part of a complex network of proteins responsible for maintaining protein homeostasis and cell survival. This exploratory hypothesis-generating study investigated the possible relationship between HSPs and unexplained infertility. Twenty-five women were recruited from an IVF clinic. Eleven were confirmed for unexplained infertility (UI), while fourteen were age- and body mass index (BMI)-matched couples with confirmed male factor infertility (MFI), acting as controls. Blood samples were obtained at day 21 of the luteal phase, and plasma measurement of 19 HSPs and co-chaperones undertaken using the slow off-rate modified aptamer (SomaScan) platform. Welch’s t-test and a permutation test were used to compare group means, and Pearson’s correlations to examine relationships with HSPs. Of the 19 proteins measured, plasma HSP70 was decreased (permutation p = 0.002) in cases with unexplained infertility, while HSC70 and STIP1 were increased (permutation p = 0.017 and p = 0.001, respectively) when compared to MFI control. HSP70 was negatively correlated to both HSC70 and STIP 1 in UI (r = −0.77, permutation p = 0.017; −0.80, permutation p = 0.003, respectively), but not in MFI, whilst HSC70 and STIP1 were positively correlated in both UI and MFI (r = 0.93, permutation p = 0.001; r = 0.65, permutation p = 0.035, respectively). The HSP70-HSC70-STIP1 axis showed HSC70-STIP1 coupling with an inverse relationship with inducible HSP70, findings that may suggest dysregulation of constitutive and stress-inducible chaperone systems in UI.